• Indonesia's Coal Price Continues to Soar in 2nd Half of 2016

    Indonesia's benchmark thermal coal price (Harga Batubara Acuan, or HBA) - a monthly price that is set by Indonesia's Energy and Mineral Resources Ministry, and which is based on domestic and international coal indices - continued its impressive rally. In December 2016 the HBA was set at USD $101.69 per metric ton, up nearly 20 percent from the HBA in the preceding month. It is now at its highest level since May 2012. Moreover, price growth between November and December was the steepest monthly rise ever in the history of the HBA.

    Lanjut baca ›

  • Stock Market & Rupiah Update Indonesia: Italy's Referendum

    Contrary to most other Asian stock indices, Indonesia's benchmark Jakarta Composite Index opened in the green zone on Monday morning (05/12). While, most markets are plagued by the outcome of Italy's referendum on Sunday (and Italian Prime Minister Matteo Renzi announcing his resignation), Indonesian stocks still seem to continue with the relief rally after the peaceful anti-Ahok demonstration on Friday (02/12). However, rupiah weakness, particularly as the US Federal Reserve may raise rates can limit the rise of local stocks.

    Lanjut baca ›

  • Indonesia Investments' Newsletter of 4 December 2016 Released

    On 4 December 2016, Indonesia Investments released the latest edition of its newsletter. This free newsletter, which is sent to our subscribers once per week, contains the most important news stories from Indonesia that have been reported on our website over the last seven days. Most of the topics involve political, social and economy-related topics such as the latest anti-Ahok demonstration, inflation, manufacturing activity, a stock market update, the macroeconomy, the tourism sector, pharmaceuticals, Indonesia's OPEC membership, and more.

    Lanjut baca ›

  • Pharmaceutical Industry Indonesia: Still Lucrative Business?

    Indonesia's pharmaceutical market will be worth USD $5.8 billion in 2017, up 5-6 percent (y/y) from the preceding year. Growth is attributed to Indonesia's universal health care program (Jaminan Kesehatan Nasional, or JKN) that was launched in 2014. As such, Indonesia's pharmaceutical industry still has great potential, says Parulian Simanjuntak, Executive Director at the International Pharmaceutical Manufacturers' Group (IPMG).

    Lanjut baca ›